SAN JOSE, Calif.--(BUSINESS WIRE)--SpineAlign Medical, Inc. (formerly SpineWorks Medical, Inc.) announced today that Gary L. Grenter will join the company as President and Chief Executive Officer and a member of the Board of Directors.
“This is an exciting time to join SpineAlign Medical, Inc. and I am delighted for the opportunity to lead it going forward,” said Grenter. “The Company has a distinctive product with the potential to address a significant medical need. The previously completed studies are very promising, and I am optimistic about its future.”
Gary joins SpineAlign with over 25 years of experience in the medical device industry and most recently was the Group President for Spacelabs Healthcare where he was responsible for all Operations in Europe, the Middle East and Africa. Prior to Spacelabs, Gary held the position of President and CEO for both Kyphon and Bioelectron in the spine arena. At Kyphon, Gary led the Company from its early growth through its initial public offering (“IPO”) in 2002. Prior to Kyphon, Gary successfully negotiated the sale of Bioelectron to Biomet, Inc., one of the world’s largest orthopedic companies. Mr. Grenter holds a B.S. in Production Management from Northern Illinois University and an M.B.A. in Management from the Rochester Institute of Technology.
“The SpineAlign Board of Directors believe Gary has the experience, integrity and energy to lead the growth of SpineAlign Medical, Inc. as a major player in the spine field,” said Mike Henson, Chairman of the Board of Directors.
Grenter will succeed Paul Chirico, SpineAlign Medical’s. founder, who has served as President and Chief Executive Officer since inception in 2005. Mr. Chirico will continue with SpineAlign Medical, Inc. as Chief Technology Officer and a Board Member.
The SpineAlign device represents the first of many new innovations in the area of minimally invasive percutaneous vertebral body reconstruction and augmentation to be developed by SpineAlign Medical. The SpineAlign device is a vertebral body implant designed to treat fractures in the thoracic or lumbar spine in patients suffering from osteoporosis. The SpineAlign Implant is an expandable metal device made from nickel-titanium (Nitinol) alloy that provides internal scaffolding to engage the vertebral body endplates, while providing and maintaining lift until bone cement is injected. SpineAlign is available in two shapes and a range of sizes to address different anatomical needs for the treatment of vertebral compression fractures. Prior to injection of bone cement, the SpineAlign Implant is fully retrievable. The SpineAlign device is not yet commercially available in the United States but is currently in clinical evaluation to support a 510(k) filing with the FDA.
SpineAlign Medical, Inc., is an early-stage medical device company dedicated to the design, development and successful commercialization of minimally-invasive products for spine procedures.
SpineAlign Medical, Inc.
Cecilia Hewett, 408-986-8950